Concise review: Epidermal grafting: The case for pluripotent stem cells

Stem Cells

Volumn 29, Issue 6, 2011, Pages 895-899

  Lemaître, Gilles ^a   Nissan, Xavier ^b   Baldeschi, Christine ^a   Peschanski, Marc ^a  

^a INSERM   (France)

^b CECS/AFM   (France)

Author keywords

Cellular therapy; Clinical trials; Embryonic stem cells; Epidermis; Pluripotent stem cells; Skin grafts

Indexed keywords

CARCINOGENICITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL THERAPY; CELL TYPE; DERMIS; EMBRYONIC STEM CELL; EMBRYONIC STRUCTURES; EPIDERMIS; EPIDERMIS CELL; FETUS; GENETIC ENGINEERING; HAIR FOLLICLE; HAPLOTYPE; HOST; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INDUSTRIALIZATION; KERATINOCYTE; LARGE SCALE PRODUCTION; PHENOTYPE; PLURIPOTENT STEM CELL; QUALITY CONTROL; SHORT SURVEY; SKIN; SKIN TRANSPLANTATION; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; KERATINOCYTES; PLURIPOTENT STEM CELLS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79957588872     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.636     Document Type: Short Survey

References (37)

1. Hierner R, Degreef H, Vranckx JJ et al. Skin grafting and wound healing-the "dermato-plastic team approach." Clin Dermatol 2005;23:343-352.
2. De Luca M, Pellegrini G, Green H. Regeneration of squamous epithelia from stem cells of cultured grafts. Regen Med 2006;1:45-57.
3. Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: Three decades later. Burns 2007;33:405-413. (Pubitemid 46702394)
4. Pellegrini G, De Luca M. Human embryonic stem cell-derived keratinocytes: How close to clinics? Cell Stem Cell 2010;6:8-9.
5. Guenou H, Nissan X, Larcher F et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: A preclinical study. Lancet 2009;374:1745-1753.
6. Green H. The birth of therapy with cultured cells. Bioessays 2008;30:897-903.
7. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979;76:5665-5668. (Pubitemid 10161674)
8. Mason C. Tissue engineering skin: A paradigm shift in wound care. Med Device Technol 2005;16:32-33.
9. Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev 2007; (2):CD001737.
10. Fivenson DP, Scherschun L, Choucair M et al. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 2003;48:886-892. (Pubitemid 36706222)
11. Halabi-Tawil M, Lionnet F, Girot R et al. Sickle cell leg ulcers: A frequently disabling complication and a marker of severity. Br J Dermatol 2008;158:339-344.
12. Macri L, Clark RA. Tissue engineering for cutaneous wounds: Selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 2009;22:83-93.
13. Foglia RP, LaQuaglia M, DiPreta J et al. Can fetal and newborn allografts survive in an immunocompetent host? J Pediatr Surg 1986;21:608-612.
14. Horch RE, Kopp J, Kneser U et al. Tissue engineering of cultured skin substitutes. J Cell Mol Med 2005;9:592-608. (Pubitemid 44159327)
15. Nanchahal J, Dover R, Otto WR. Allogeneic skin substitutes applied to burns patients. Burns 2002;28:254-257.
16. Youn SW, Kim DS, Cho HJ et al. Cellular senescence induced loss of stem cell proportion in the skin in vitro. J Dermatol Sci 2004;35:113-123. (Pubitemid 38969034)
17. Fortunel NO, Hatzfeld JA, Rosemary PA et al. Long-term expansion of human functional epidermal precursor cells: Promotion of extensive amplification by low TGF-beta1 concentrations. J Cell Sci 2003;116(pt 19):4043-4052. (Pubitemid 37279318)
18. Teo AK, Vallier L. Emerging use of stem cells in regenerative medicine. Biochem J 15; 428:11-23.
19. Come J, Nissan X, Aubry L et al. Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Tissue Eng Part C Methods 2008;14:289-298.
20. Thomas RJ, Anderson D, Chandra A et al. Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng 2009;102:1636-1644.
21. Andrews PW, Benvenisty N, McKay R et al. The International Stem Cell Initiative: Toward benchmarks for human embryonic stem cell research. Nat Biotechnol 2005;23:795-797.
22. Isasi RM, Knoppers BM. Governing stem cell banks and registries: Emerging issues. Stem Cell Res 2009;3:96-105.
23. Akopian V, Andrews PW, Beil S et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim 2010;46:247-258.
24. Hovatta O, Jaconi M, Tohonen V et al. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One 2010;5:e10263.
25. Lefort N, Feyeux M, Bas C et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 2008;26:1364-1366.
26. Robertson NJ, Brook FA, Gardner RL et al. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci USA 2007;104:20920-20925.
27. Hohlfeld J, de Buys Roessingh A, Hirt-Burri N et al. Tissue engineered fetal skin constructs for paediatric burns. Lancet 2005;366:840-842. (Pubitemid 41557384)
28. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002;2:859-871. (Pubitemid 37328708)
29. Taylor CJ, Bolton EM, Pocock S et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025. (Pubitemid 41773377)
30. Nakajima F, Tokunaga K, Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 2007;25:983-985. (Pubitemid 46572595)
31. Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol 2008;26:739-740. (Pubitemid 351961440)
32. Zaulyanov L, Kirsner RS. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin Interv Aging 2007;2:93-98.
33. Fang D, Leishear K, Nguyen TK et al. Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells 2006;24:1668-1677. (Pubitemid 44474180)
34. Stojkovic P, Lako M, Stewart R et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 2005;23:306-314. (Pubitemid 40404449)
35. Karlsson C, Emanuelsson K, Wessberg F et al. Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res 2009;3:39-50.
36. Xiong C, Xie CQ, Zhang L et al. Derivation of adipocytes from human embryonic stem cells. Stem Cells Dev 2005;14:671-675. (Pubitemid 43201901)
37. Laflamme K, Roberge CJ, Pouliot S et al. Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native blood vessels. Tissue Eng 2006;12:2275-2281. (Pubitemid 44734985)